Externally-used medicinal composition for treating cold arthritis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for external use of drugs and arthritis, applied in the field of external Chinese medicine, can solve problems such as bleeding, ulcers, perforation, unsatisfactory curative effect, and pain costs for patients
Inactive Publication Date: 2015-05-20
季一艮
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] At present, the treatment of cold arthritis at home and abroad includes western medicine, surgery, traditional Chinese medicine, acupuncture and massage, etc. Western medicine generally only has an analgesic function, mainly to relieve clinical symptoms, and taking western medicine is likely to cause upper gastrointestinal bleeding, ulcers, Perforation, etc.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0028] An external pharmaceutical composition for treating cold arthritis proposed by the present invention, its raw materials include: 45 parts of dried ginger, 25 parts of cassia cinnamon, 4 parts of Aconitum aconiti, 6 parts of Evodia rutaecarpa, 4 parts of fenugreek, 17 parts of Clematis, 8 parts of Elderberry, 12 parts of Qiannianjian, 4 parts of Sangjishen, 55 parts of Chuanxiong, 15 parts of Achyranthes bidentata, 6 parts of Spatholobus, and 8 parts of Safflower.
Embodiment 2
[0030] An external pharmaceutical composition for treating cold arthritis proposed by the present invention, its raw materials include: 53 parts of dried ginger, 18 parts of cinnamon, 5.6 parts of Aconitum aconiti, 4.3 parts of Evodia rutaecarpa, 5.3 parts of fenugreek, 14 parts of Clematis, 11 parts of Elderberry, 9 parts of Qiannianjian, 5.1 parts of Sangjishen, 47 parts of Chuanxiong, 22 parts of Achyranthes bidentata, 4.5 parts of Millet Spatholobus, and 11 parts of Safflower.
Embodiment 3
[0032] An external pharmaceutical composition for treating cold arthritis proposed by the present invention, its raw materials include: 50 parts of dried ginger, 20 parts of cinnamon, 5 parts of Aconitum aconiti, 5 parts of Evodia rutaecarpa, 5 parts of fenugreek, 15 parts of Clematis, 10 parts of Elderberry, 10 parts of Qiannianjian, 5 parts of Sangjishen, 50 parts of Chuanxiong, 20 parts of Achyranthes bidentata, 5 parts of Spatholobus, and 10 parts of Safflower.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses an externally-used medicinal composition for treating cold arthritis. The medicinal composition is prepared from the following raw materials in parts by weight: 45-55 parts of dried ginger, 15-25 parts of cassia barks, 4-6 parts of processed kusnezoff monkshood roots, 4-6 parts of medicinal evodia fruits, 4-6 parts of common fenugreek seeds, 13-17 parts of clematis roots, 8-12 parts of williams elder twigs, 8-12 parts of obscured homalomena rhizomes, 4-6 parts of Chinese taxillus twigs, 45-55 parts of Szechuan lovage rhizomes, 15-25 parts of twotooth achyranthes roots, 4-6 parts of suberect spatholobus stems and 8-12 parts of safflowers. The medicinal composition disclosed by the invention has the functions of strengthening the body resistance to eliminate pathogenic factors, treating both symptoms and root causes, warming middle jiao to dispel cold, recuperating depleted yang, invigorating pulse, promoting the circulation of blood and stimulating the menstrual flow, can be used for treating cold arthritis and can achieve a total effective rate of 96%.
Description
technical field [0001] The invention relates to the technical field of traditional Chinese medicine for external use, in particular to an external pharmaceutical composition for treating cold arthritis. Background technique [0002] Cold arthritis mostly belongs to the category of "arthritis" in traditional Chinese medicine. It is mainly due to the deficiency of liver and kidney yin, which leads to the weakness of human body's righteousness, unable to resist external evils such as wind, cold, and damp. Obliteration of the meridians, blockage of joints, stagnation of qi and blood coagulation, over time lead to joint deformation, swelling, difficulty in flexion and extension, numbness and pain, and what is more, muscle atrophy and disability. Because cold is a yin evil, its nature is suspicious and stagnant. Main symptoms: cool muscles, joints and skin, severe fixed pain or contracture, tight or deep pulse, pale tongue, white or slippery fur. The characteristics of cold arth...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.